McCaul, Luttrell Urge President Trump to Expand Veterans' Access to Life-Saving Neuroplastogen Treatment

WASHINGTON - Today, Congressman Michael McCaul (R-Texas) - chairman emeritus of the House Foreign Affairs Committee - and Congressman Morgan Luttrell (R-Texas) wrote a letter to President Donald Trump, highlighting the mounting evidence that neuroplastogen medicines, particularly ibogaine, can accelerate the healing process for veterans struggling with mental health and substance addictions. In the letter, McCaul and Luttrell urged the Trump administration to expand access to these life-saving treatments for our nation's heroes.

"Every day, an average of 17 veterans take their own lives. These are men and women who survived combat, who came home, and who then lost a quieter and longer war against the invisible wounds they carried with them. Evidence is mounting that neuroplastogen medicines, such as ibogaine, can provide a durable path to healing where traditional medicine has failed," the members wrote.

They continued, "This breakthrough rests on a new understanding of how these medicines interact with the brain. Unlike traditional treatments that manage symptoms, ibogaine appears to work at a deeper level, stimulating the brain's own repair mechanisms and encouraging the growth of new neural connections that can bypass the damaged pathways underlying PTSD, depression, TBI, and addiction. A 2024 study from Stanford University found that a single ibogaine treatment produced dramatic reductions in PTSD, depression, and anxiety among veterans with traumatic brain injuries, along with meaningful improvements in cognitive function. No approved treatment has come close to this level of impact, and larger controlled trials are needed to fully understand it."

Click here to read full text of the letter.

###